Triazole compounds that modulate HSP90 activity

Novel triazole compounds targeting Hsp90 activity address the limitations of current cancer treatments by disrupting multiple oncogenic pathways, offering a more effective approach to cancer treatment by inhibiting Hsp90 and its client proteins.

CA2653332A1Inactive Publication Date: 2007-12-06SYNTA PHARMA CORP
0 Cites 0 Cited by

Patent Information

Application Number
CA2653332
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2006-05-25
Filing Date
2007-05-25
Publication Date
2007-12-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current cancer treatments often target only one molecular pathway, leading to multidrug resistance and ineffective tumor regression, as most chemotherapeutic agents fail to address the complex network of signaling pathways involved in cancer progression.

Method used

Development of novel triazole compounds that inhibit Hsp90 activity, facilitating the degradation of client proteins involved in signal transduction, thereby short-circuiting multiple pathways contributing to cancer progression.

Benefits of technology

Inhibiting Hsp90 activity with these compounds can lead to simultaneous disruption of several oncogenic pathways, potentially resulting in more effective tumor regression and reduced development of multidrug-resistant tumors.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
Need to check novelty before this filing date? Find Prior Art